Morphine inhibits mucosal antibody responses and TGF-β mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 3677-3681

  Peng, X ^a   Cebra, J J ^a   Adler, M W ^a   Meissler J J , Jr ^a   Cowan, A ^a   Feng, P ^a   Eisenstein, T K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; MORPHINE DERIVATIVE; NALTREXONE; PLACEBO; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREACTIVITY; INTESTINE LYMPHATIC TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035478936     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.3677     Document Type: Article

References (55)

1. The periaqueductal gray matter mediates opiate-induced immunosuppression
2. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism
3. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice
4. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages
5. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids
6. Immunosuppressive effects of chronic morphine treatment in mice
7. Morphine pellet-induced immunomodulation in mice: Temporal relationships
8. Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone
9. Opiate receptor mediated regulation of the immune response in vivo
10. Immunomodulatory activity of μ and κ-selective opioid agonists
11. Differential effects of morphine and naltrexone on the antibody response in various mouse strains
12. Mouse strain differences in immunosuppression by opioids in vitro
13. Morphine increases susceptibility to oral Salmonella ryphimurium infection
14. Lethality of morphine in mice infected with Toxoplasma gondii
15. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
16. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response
17. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen
18. The effect of opiates on the intestinal immune response to cholera toxin in mice
19. Chronic morphine administration: Plasma levels and withdrawal syndrome in rats
20. Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii
21. Transforming growth factor-β directs IgA switching in human B cells
22. Recombinant murine IL-5 induces high rate of IgA synthesis in cycling IgA-positive Peyer's patch B cells
23. Interleukins and IgA synthesis: Human and murine interleukin-6 induce high rate secretion in IgA-committed B cells
24. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo
25. The role of interleukin-6 in mucosal IgA antibody responses in vivo
26. Gastrointestinal receptors and drugs in motility disorders
27. The central and peripheral influences of opioids on gastrointestinal propulsion
28. Action of opiates on gastrointestinal function
29. Opiate binding sites in mucosa of pig small intestine
30. Cloning of δ-opioid receptor by functional expression
31. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
32. μ Opiate receptors: cDNA Cloning and expression
33. Cloning and functional comparison of κ and δ opioid receptors from mouse brain
34. Molecular cloning and expression of a rat κ opioid receptor
35. Diarrhoea associated with intestinal inflammation increases the potency of μ and δ opioids on the inhibition of gastrointestinal transit in mice
36. Regulation of gastrointestinal function by multiple opioid receptors
37. μ-Opioid receptor-knockout mice: The role of μ-opioid receptor in gastrointestinal transit
38. Antibodies and antisense oligodeoxynucleotides to μ-opioid receptors selectively block the effects of μ-opioid agonists on intestinal transit and permeability in mice
39. Orally administered κ as well as μ opiate agonists delay gastrointestinal transit time in the guinea pig
40. Regulation of IgA synthesis and immune response by T cells and interleukins
41. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes
42. Transforming growth factor β1 increases IgA isotype switching at the clonal level
43. Effects of opiates on transforming growth factor β(TGF-β) expression in porcine peripheral blood leukocytes
44. Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures
45. Targeted disruption of the mouse transforming growth factor-β gene results in multifocal inflammatory disease
46. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encepbalomyelitis
47. Serious infections other than human immunodeficiency virus among intravenous drug users
48. Opiates and infection
49. Drugs of abuse and infectious disease
50. Penetration of the intestinal epithelium by various microorganisms
51. Experimental Shigella infections: Characteristics of a fatal infection produced in guinea pigs
52. Morphine induces sepsis in mice
53. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: Implications of an atypical μ-opioid receptor
54. Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for the transmission of AIDS
55. Direct in vitro infection of human intestine with HIV